Oxymetazoline inhibits proinflammatory reactions: Effect on arachidonic acid-derived metabolites

Journal of Pharmacology and Experimental Therapeutics

Volumn 316, Issue 2, 2006, Pages 843-851

  Beck Speier, Ingrid ^a   Dayal, Niru ^a   Karg, Erwin ^a   Maier, Konrad L ^a   Schumann, Gabriele ^a   Semmler, Manuela ^a   Koelsch, Stephan M ^b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b Merck Selbstmedikation GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; 8 ISOPROSTANE; ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID DERIVATIVE; LEUKOTRIENE B4; OXYMETAZOLINE; PHOSPHOLIPASE A2; PROSTAGLANDIN E2;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; IMMUNOMODULATION; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; NONHUMAN; OPSONIZATION; OXIDATION; OXIDATIVE STRESS; PARTICULATE MATTER; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RESPIRATORY BURST;

ANIMALS; ARACHIDONATE 15-LIPOXYGENASE; ARACHIDONATE 5-LIPOXYGENASE; ARACHIDONIC ACID; CARBON; CELLS, CULTURED; DOGS; MACROPHAGES, ALVEOLAR; NASAL DECONGESTANTS; OXIDATIVE STRESS; OXYMETAZOLINE; PARTICLE SIZE; PHAGOCYTOSIS; RESPIRATORY BURST; ZYMOSAN;

EID: 31144440575     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.105.093278     Document Type: Article

References (40)

1. Allen RC (1986) Phagocytic leukocyte oxygenation activities and chemiluminescence: a kinetic approach to analysis, Methods Enzymol 133:449-493.
2. Ananaba GA and Anderson LJ (1991) Antibody enhancement of respiratory syncytial virus stimulation of leukotriene production by a macrophage cell line. J Virol 65:5052-5060.
3. Beck-Speier I, Dayal N, Karg E, Maier KL, Schumann G, Schulz H, Semmler M, Takenaka S, Stettmaier K, Bors W, et al. (2005) Oxidative stress and lipid mediators induced in alveolar macrophages by ultrafine particles. Free Radic Biol Med 38:1080-1092.
4. Behera AK, Kumar M, Matsuse H, Lockey RF, and Mohapatra SS (1998) Respiratory syncytial virus induces the expression of 5-lipoxygenase and endothelin-1 in bronchial epithelial cells. Biochem Biophys Res Commun 251:704-709.
5. 4 on nasal mucosal blood flow, nasal airway resistance and nasal secretions in humans. Clin Allergy 16:289-297.
6. Bjerknes R and Steinsvag K (1993) Inhibition of human neutrophil actin polymerization, phagocytosis and oxidative burst by components of decongestive nose drops. Pharmacol Toxicol 73:41-45.
7. Denzlinger C (1996) Biology and pathophysiology of leukotrienes. Crit Rev Oncol Hematol 23:167-223.
8. 2+ control time not space. J Cell Sci 116:2857-2865.
9. 4 levels during viral upper respiratory tract infections. Ann Allergy Asthma Immunol 91:270-274.
10. Gentile DA and Skoner DP (2001) Viral rhinitis. Curr Allergy Asthma Rep 1:227-234.
11. Girotti M, Evans JH, Burke D, and Leslie CC (2004) Cytosolic phospholipases A2 translocates to forming phagosomes during phagocytosis of zymosan in macrophages. J Biol Chem 279:19113-19121.
12. 2, E-prostanoid 3-receptors and potassium channels. Am J Respir Crit Care Med 166:657-662.
13. Gwaltney JM (1995) Rhinovirus infection of the normal human airway. Am J Respir Crit Care Med 152:S36-S39.
14. Gwaltney JM (2002) Clinical significance and pathogenesis of viral respiratory infections. Am J Med 112(6A):13S-18S.
15. Kaulbach HC, White MV, Igarashi Y, Hahn BK, and Kaliner MA (1993) Estimation of nasal epithelial lining fluid using urea as a marker. J Allergy Clin Immunol 92:457-465.
16. Kharitonov SA, Yates D, and Barnes PJ (1995) Increased nitric oxide in exhaled air of normal human subjects with upper airway respiratory tract infections. Eur Respir J 8:295-297.
17. Levy BD, Clish CB, Schmidt B, Gronert K, and Serhan CN (2001) Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol 2:612-619.
18. Li Y, Zhu H, Kuppusamy P, Roubaund V, Zweier JL, and Trush MA (1998) Validation of lucigenin (bis-N-methylacridinium) as chemilumigenic probe for detecting superoxide anion radical production by enzymatic and cellular systems. J Biol Chem 273:2015-2023.
19. Liu YC, Khawaja AM, and Rogers DF (1998) Effects of the cysteinyl leukotrienes receptor antagonists pranlukast and zafirlukast on tracheal mucus secretion in ovalbumin-sensitized guinea pigs in vitro. Br J Pharmacol 124:563-571.
20. Maier K, Beck-Speier I, Dayal N, Heilmann P, Hinze H, Lenz A-G, Leuschel L, Matejkova E, Miaskowski U, and Heyder J (1992) Early responses of the canine respiratory tract following long-term exposure to a sulfur(IV) aerosol at low concentration: II. Biochemistry and cell biology of lung lavage fluid. Inhal Toxicol 4:175-195.
21. Martin U, Bryden K, Devoy M, and Howarth P (1996) Increased levels of exhaled nitric oxide during nasal and oral breathing in subjects with seasonal rhinitis. J. Allergy Clin Immunol 97:768-772.
22. Meltzer EO, Malmstrom K, Lu S, Prenner BM, Wei LX, Weinstein SF, Wolfe JD, and Reiss TF (2000) Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial. J Allergy Clin Immunol 105:917-922.
23. Naclerio RM, Baroody FM, and Togias AG (1991) The role of leukotrienes in allergic rhinitis: a review. Am Rev Respir Dis 143:S91-S95.
24. Naveau B (2005) Dual inhibition of cyclo-oxygenases and 5-lipoxygenase: a novel therapeutic approach to inflammation? Joint Bone Spine 72:199-201.
25. Pereg D and Lishner M (2005) Non-steroidal anti-inflammatory drugs for the prevention and treatment of cancer. J Intern Med 258:115-123.
26. Perez-Novo CA, Watelet JB, Claeys C, Van Cauwenberge P, and Bachert C (2005) Prostaglandin, leukotrienes and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis. J Allergy Clin Immunol 115:1189-1196.
27. Roberts LJ and Morrow JD (2000) Measurement of F2-isoprostanes as an index of oxidative stress in-vivo. Free Radic Biol Med 28:505-513.
28. 2 release from human granulocytes during phagocytosis. J Clin Investig 60:1266-1279.
29. Roth C, Ferron GA, Karg E, Lentner B, Schumann G, Takenaka S, and Heyder J (2004) Generation of ultrafine particles by spark discharging. Aerosol Sci Technol 38:228-235.
30. Serhan CN, Jain A, Marleau S, Clish C, Kantarci A, Behbehani B, Colgan SP, Stahl GL, Merched A, Petasis NA, et al. (2003) Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol 171:6856-6865.
31. Sherwood ME and Richardson TM (1988) Phagocytosis by trabecular meshwork cells: sequence of events in cats and monkeys. Exp Eye Res 46:881-895.
32. van Benten IJ, KleinJan A, Neijens HJ, Osterhaus ADME, and Fokkens WJ (2001) Prolonged nasal eosinophilia in allergic patients after common cold. Allergy 56:949-956.
33. van Benten IJ, van Drunen CM, Koopman LP, van Middlekoop BC, Hop WCJ, Osterhaus ADME, Neijens HJ, and Fokkens WJ (2005) Age- and infection-related maturation of the nasal immune response in 0-2-year-old children. Allergy 60:226-232.
34. Van Cauwenberge PB, van Kempern MJP, and Bachert C (2000) The common cold. Acta Otorhinolaryngol Belg 54:397-401.
35. Vancheri C, Mastruzzo D, Sortino MA, and Crimi N (2004) the lung as a privileged site for the beneficial actions of PGE2. Trends Immunol 25:40-46.
36. Vanderhoek JY, Bryant RW, and Bailey JM (1980) Inhibition of leukotrienes biosynthesis by leukocyte product 15-hydroxy-5,8,11,13-eicosatetraenoic acid. J Biol Chem 255:10064-10066.
37. van Schaik SM, Tristram DA, Negpal IS, Hintz KM, Welliver RC, and Welliver RC (1999) Increased production of IFN-γ and cysteinyl leukotrienes in virus-induced wheezing. J Allergy Clin Immunol 103:630-636.
38. Westerveld GJ, Scheeren RA, Dekker I, Griffioen DH, Voss HP, and Bast A (1995) Anti-oxidant actions of oxymethazoline and xylomethazoline. Eur J Pharmacol 291:27-31.
39. Westerveld GJ, Voss HP, van der Hee RM, de Haan-Koelewijn GJN, den Hartog GJM, Scheeren RA, and Bast A (2000) Inhibition of nitric oxide synthase by nasal decongestants. Eur Respir J 16:437-444.
40. Winther B, Gwaltney JM, Mygind N, and Hendley JO (1998) Viral-induced rhinitis. Am J Rhinol 12:17-20.